Acurx Pharmaceuticals LLC (ACXP) — Financial Flexibility Index
Acurx Pharmaceuticals LLC (ACXP) has a Financial Flexibility Index of -0.56x as of March 2026. Free cash flow of $-1.41 Billion (operating CF $-1.41 Billion minus capex $0.00) represents -1% of total liabilities ($2.53 Billion). Also explore Acurx Pharmaceuticals LLC net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acurx Pharmaceuticals LLC Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Acurx Pharmaceuticals LLC across 7 annual periods. See how leveraged is Acurx Pharmaceuticals LLC's balance sheet to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Acurx Pharmaceuticals LLC (2019–2025)
Year-by-year free cash flow to debt coverage for Acurx Pharmaceuticals LLC. For the full company profile including market capitalisation, see market cap of Acurx Pharmaceuticals LLC.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2803.78x | $-6.79 Billion | $-6.79 Billion | $2.42 Million | ▼ -87464.5% |
| 2024 | -3.20x | $-10.38 Million | $-10.38 Million | $3.24 Million | ▲ +0.6% |
| 2023 | -3.22x | $-9.80 Million | $-9.80 Million | $3.04 Million | ▲ +11.9% |
| 2022 | -3.66x | $-7.54 Million | $-7.54 Million | $2.06 Million | ▲ +38.4% |
| 2021 | -5.94x | $-5.01 Million | $-5.01 Million | $843.91K | ▲ +7.4% |
| 2020 | -6.42x | $-3.35 Million | $-3.35 Million | $522.43K | ▼ -175.5% |
| 2019 | -2.33x | $-3.99 Million | $-3.99 Million | $1.71 Million | — |